Venkateshwaran Krishnaswami - Search Results

Year	Number of Results
2015	1
2017	4
2018	5
2019	4
2020	4
2021	6
2022	4
2023	1
2024	0

1

Nanoformulations - Insights Towards Characterization Techniques.

Krishnaswami V, Sugumaran A, Perumal V, Manavalan M, Kondeti DP, Basha SK, Ahmed MA, Kumar M, Vijayaraghavalu S. Krishnaswami V, et al. Curr Drug Targets. 2022;23(14):1330-1344. doi: 10.2174/1389450123666220822094248. Curr Drug Targets. 2022. PMID: 35996238 Review.

2

Current Drug Targeting using siRNA-based Nano Therapeutics for Pulmonary Diseases.

Krishnaswami V, Kandasamy R. Krishnaswami V, et al. Curr Pharm Des. 2022;28(28):2279-2282. doi: 10.2174/1381612828666220727144223. Curr Pharm Des. 2022. PMID: 35894459 Review.

3

Novel Nanocarriers for the Treatment of Wound Healing.

Krishnaswami V, Raju NS, Alagarsamy S, Kandasamy R. Krishnaswami V, et al. Curr Pharm Des. 2020;26(36):4591-4600. doi: 10.2174/1381612826666200701203432. Curr Pharm Des. 2020. PMID: 32611292 Review.

4

Biological macromolecules for ophthalmic drug delivery to treat ocular diseases.

Krishnaswami V, Kandasamy R, Alagarsamy S, Palanisamy R, Natesan S. Krishnaswami V, et al. Int J Biol Macromol. 2018 Apr 15;110:7-16. doi: 10.1016/j.ijbiomac.2018.01.120. Epub 2018 Jan 31. Int J Biol Macromol. 2018. PMID: 29378276 Review.

5

Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis.

Muruganantham S, Krishnaswami V, Alagarsamy S, Kandasamy R. Muruganantham S, et al. Among authors: krishnaswami v. Curr Drug Targets. 2021;22(4):399-419. doi: 10.2174/1389450121666201027125303. Curr Drug Targets. 2021. PMID: 33109044 Review.

6

The Role of Nano-ophthalmology in Treating Dry Eye Disease.

Natesan S, Boddu SHS, Krishnaswami V, Shahwan M. Natesan S, et al. Among authors: krishnaswami v. Pharm Nanotechnol. 2020;8(4):258-289. doi: 10.2174/2211738508666200628034227. Pharm Nanotechnol. 2020. PMID: 32600244 Review.

7

Guar gum based oral films for hypertensive urgencies.

Aravindaraj N, Suresh J, Krishnaswami V, Alagarsamy S, Kandasamy R. Aravindaraj N, et al. Among authors: krishnaswami v. Nat Prod Res. 2022 Dec;36(24):6470-6473. doi: 10.1080/14786419.2022.2039919. Epub 2022 Feb 15. Nat Prod Res. 2022. PMID: 35167380

8

Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.

Sethuraman V, Janakiraman K, Krishnaswami V, Kandasamy R. Sethuraman V, et al. Among authors: krishnaswami v. Curr Drug Targets. 2021;22(8):947-966. doi: 10.2174/1389450122999210128180058. Curr Drug Targets. 2021. PMID: 33511953 Review.

9

Microbiome and the inflammatory pathway in peri-implant health and disease with an updated review on treatment strategies.

Banu Raza F, Vijayaragavalu S, Kandasamy R, Krishnaswami V, Kumar V A. Banu Raza F, et al. Among authors: krishnaswami v. J Oral Biol Craniofac Res. 2023 Mar-Apr;13(2):84-91. doi: 10.1016/j.jobcr.2022.11.005. Epub 2022 Dec 2. J Oral Biol Craniofac Res. 2023. PMID: 36504486 Free PMC article. Review.

10

Combinatorial analysis of quercetin and resveratrol by HPTLC in Sesbania grandiflora/phyto-based nanoformulations.

Sethuraman V, Janakiraman K, Krishnaswami V, Natesan S, Kandasamy R. Sethuraman V, et al. Among authors: krishnaswami v. Nat Prod Res. 2021 Jul;35(13):2243-2248. doi: 10.1080/14786419.2019.1662012. Epub 2019 Sep 9. Nat Prod Res. 2021. PMID: 31496285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year